SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-007933
Filing Date
2017-07-18
Accepted
2017-07-18 15:47:06
Documents
45
Period of Report
2017-05-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 424283
2 ex-31.htm EX-31 19063
3 ex-32.htm EX-32 8329
4 image1_001.jpg GRAPHIC 15316
  Complete submission text file 0001493152-17-007933.txt   2372422

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ptlf-20170531.xml EX-101.INS 288683
6 XBRL SCHEMA FILE ptlf-20170531.xsd EX-101.SCH 30811
7 XBRL CALCULATION FILE ptlf-20170531_cal.xml EX-101.CAL 34563
8 XBRL DEFINITION FILE ptlf-20170531_def.xml EX-101.DEF 104951
9 XBRL LABEL FILE ptlf-20170531_lab.xml EX-101.LAB 218329
10 XBRL PRESENTATION FILE ptlf-20170531_pre.xml EX-101.PRE 172001
Mailing Address 38 WEST MAIN STREET HANCOCK MD 21750
Business Address 38 WEST MAIN STREET HANCOCK MD 21750 844-473-8543
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

IRS No.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52445 | Film No.: 17969516
SIC: 2860 Industrial Organic Chemicals